{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:40Z","timestamp":1792783420584,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Queensland University of Technology","id":[{"id":"https:\/\/ror.org\/03pnv4752","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"DOI":"10.1007\/s40258-026-01073-z","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:18:33Z","timestamp":1791551913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of Annual Atrial Fibrillation Screening Compared with Current Opportunistic Screening in Australian Primary Care: A Model-Based Economic Evaluation"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6765-8710","authenticated-orcid":false,"given":"Ureni","family":"Halahakone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera","family":"Senanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"McCreanor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Parsonage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"1","key":"1073_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5694\/mja2.51803","volume":"218","author":"K Giskes","year":"2023","unstructured":"Giskes K, Lowres N, Orchard J, Li J, McKenzie K, Hespe CM, et al. Increasing screening for atrial fibrillation in general practice: the Atrial Fibrillation Self-Screening, Management And guideline-Recommended Therapy (AF Self-SMART) study. Med J Aust. 2023;218(1):27\u201332.","journal-title":"Med J Aust"},{"key":"1073_CR2","unstructured":"Harber J. The Economist Intelligence Unit. Preventing stroke: uneven progress. 2017."},{"key":"1073_CR3","unstructured":"Australian Bureau of Statistics. Patient experiences. Canberra; 2023\u20132024."},{"issue":"10","key":"1073_CR4","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","volume":"27","author":"D Brieger","year":"2018","unstructured":"Brieger D, Amerena J, Attia J, Bajorek B, Chan KH, Connell C, et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Heart Lung Circ. 2018;27(10):1209\u201366.","journal-title":"Heart Lung Circ"},{"key":"1073_CR5","unstructured":"Wisbey M. \u2018Just insulting\u2019: RACGP demands ECG restriction reversal. News GP. 2024."},{"issue":"6","key":"1073_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.hlc.2023.03.014","volume":"32","author":"U Halahakone","year":"2023","unstructured":"Halahakone U, Senanayake S, McCreanor V, Parsonage W, Kularatna S, Brain D. Cost-effectiveness of screening to identify patients with atrial fibrillation: a systematic review. Heart Lung Circ. 2023;32(6):678\u201395.","journal-title":"Heart Lung Circ"},{"issue":"6","key":"1073_CR7","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1160\/TH14-03-0231","volume":"111","author":"N Lowres","year":"2014","unstructured":"Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6):1167\u201376.","journal-title":"Thromb Haemost"},{"issue":"18","key":"1073_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.120.017080","volume":"9","author":"J Orchard","year":"2020","unstructured":"Orchard J, Jialin L, Freedman B, Webster R, Salkeld G, Hespe C, et al. Atrial fibrillation screen, management, and guideline-recommended therapy in the rural primary care setting: a cross-sectional study and cost-effectiveness analysis of eHealth tools to support all stages of screening. J Am Heart Assoc. 2020;9(18):1\u201315.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1073_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12875-020-01151-8","volume":"21","author":"KC Wong","year":"2020","unstructured":"Wong KC, Kok C, Marschner S, Usherwood T, Chow CK. Screening for atrial fibrillation and other arrhythmias in primary care. BMC Fam Pract. 2020;21(1):79.","journal-title":"BMC Fam Pract"},{"issue":"19","key":"1073_CR10","first-page":"iii","volume":"9","author":"FDR Hobbs","year":"2005","unstructured":"Hobbs FDR, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005;9(19):iii\u201374.","journal-title":"Health Technol Assess"},{"issue":"2","key":"1073_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1258\/096914104774061092","volume":"11","author":"K Maeda","year":"2004","unstructured":"Maeda K, Shimbo T, Fukui T. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan. J Med Screen. 2004;11(2):97\u2013102.","journal-title":"J Med Screen"},{"issue":"4","key":"1073_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s40258-019-00542-y","volume":"18","author":"M Oguz","year":"2020","unstructured":"Oguz M, Lanitis T, Li X, Wygant G, Singer DE, Friend K, et al. Cost-effectiveness of extended and one-time screening versus no screening for non-valvular atrial fibrillation in the USA. Appl Health Econ Health Policy. 2020;18(4):533\u201345.","journal-title":"Appl Health Econ Health Policy"},{"issue":"29","key":"1073_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21290","volume":"21","author":"NJ Welton","year":"2017","unstructured":"Welton NJ, McAleenan A, Thom HH, Davies P, Hollingworth W, Higgins JP, et al. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2017;21(29):1\u2013236.","journal-title":"Health Technol Assess"},{"issue":"6","key":"1073_CR14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jval.2012.04.014","volume":"15","author":"AH Briggs","year":"2012","unstructured":"Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6. Value Health. 2012;15(6):835\u201342.","journal-title":"Value Health"},{"issue":"6","key":"1073_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jval.2012.06.012","volume":"15","author":"JJ Caro","year":"2012","unstructured":"Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices\u2014overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1. Value Health. 2012;15(6):796\u2013803.","journal-title":"Value Health"},{"issue":"5","key":"1073_CR16","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/0272989X12454941","volume":"32","author":"M Roberts","year":"2012","unstructured":"Roberts M, Russell LB, Paltiel AD, Chambers M, McEwan P, Krahn M. Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2. Med Decis Making. 2012;32(5):678\u201389.","journal-title":"Med Decis Making"},{"issue":"6","key":"1073_CR17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jval.2012.06.014","volume":"15","author":"U Siebert","year":"2012","unstructured":"Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Value Health. 2012;15(6):812\u201320.","journal-title":"Value Health"},{"issue":"18","key":"1073_CR18","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) study. JAMA. 2001;285(18):2370\u20135.","journal-title":"JAMA"},{"issue":"2","key":"1073_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"key":"1073_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2025.105319","volume":"156","author":"Q Xia","year":"1992","unstructured":"Xia Q, McPhail SM, Afoakwah C, Vo LK, Lim M, Brain D, et al. Growth and changing landscape of the cost-utility literature: an Australian perspective, 1992\u20132022. Health Policy. 1992;156:105319.","journal-title":"Health Policy"},{"key":"1073_CR21","unstructured":"Pro T. TreeAge Software. Williamstown: TreeAge Software, LLC; 2025."},{"key":"1073_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.586370","volume":"12","author":"WM Bezabhe","year":"2021","unstructured":"Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Curtain C, Salahudeen MS, et al. Ten-year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation. Front Pharmacol. 2021;12:586370.","journal-title":"Front Pharmacol"},{"issue":"9","key":"1073_CR23","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3748\/wjg.v11.i9.1365","volume":"11","author":"KC Thomopoulos","year":"2005","unstructured":"Thomopoulos KC, Mimidis KP, Theocharis GJ, Gatopoulou AG, Kartalis GN, Nikolopoulou VN. Acute upper gastrointestinal bleeding in patients on long-term oral anticoagulation therapy: endoscopic findings, clinical management and outcome. World J Gastroenterol. 2005;11(9):1365\u20138.","journal-title":"World J Gastroenterol"},{"key":"1073_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejim.2018.11.003","volume":"61","author":"MV Lenti","year":"2019","unstructured":"Lenti MV, Pasina L, Cococcia S, Cortesi L, Miceli E, Caccia Dominioni C, et al. Mortality rate and risk factors for gastrointestinal bleeding in elderly patients. Eur J Intern Med. 2019;61:54\u201361.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"1073_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1332\/174426410X482999","volume":"6","author":"I Shemilt","year":"2010","unstructured":"Shemilt I, James T, Marcello M. A web-based tool for adjusting costs to a specific target currency and price year. Evid Policy. 2010;6(1):51\u20139.","journal-title":"Evid Policy."},{"key":"1073_CR26","doi-asserted-by":"publisher","unstructured":"White NaB, R. ShinyPrior: a tool for estimating probability distributions from published evidence: OSF Preprints; 2023. Available from: https:\/\/doi.org\/10.31219\/osf.io\/zf62e.","DOI":"10.31219\/osf.io\/zf62e"},{"issue":"6","key":"1073_CR27","first-page":"449","volume":"58","author":"TB Abebe","year":"2019","unstructured":"Abebe TB, Morton JI, Ilomaki J, Ademi Z. Future burden of ischemic stroke in Australia: impact on health outcomes between 2019 and 2038. Neuroepidemiology. 2019;58(6):449\u201359.","journal-title":"Neuroepidemiology"},{"key":"1073_CR28","volume-title":"Atrial fibrillation in Australia","author":"Australian Institute of Health and Welfare","year":"2020","unstructured":"Australian Institute of Health and Welfare. Atrial fibrillation in Australia. Canberra: AIHW; 2020."},{"issue":"2","key":"1073_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","volume":"42","author":"LB Goldstein","year":"2011","unstructured":"Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42(2):517\u201384.","journal-title":"Stroke"},{"key":"1073_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.31128\/AJGP-02-25-7554","volume":"54","author":"R Osman","year":"2025","unstructured":"Osman R, Anderson J, Katelaris A, Dooley S, Dartnell J. Navigating the risk of stroke and bleeding in atrial fibrillation. Aust J Gen Pract. 2025;54:315\u20138.","journal-title":"Aust J Gen Pract"},{"key":"1073_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2023.107584","volume":"173","author":"S Hewage","year":"2009","unstructured":"Hewage S, Jadamba A, Brain D, Parsonage W, McPhail S, Kularatna S. Global and regional burden of ischemic stroke associated with atrial fibrillation, 2009\u20132019. Prev Med. 2009;173:107584.","journal-title":"Prev Med"},{"issue":"26","key":"1073_CR32","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"DJ Gladstone","year":"2014","unstructured":"Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467\u201377.","journal-title":"N Engl J Med"},{"issue":"26","key":"1073_CR33","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478\u201386.","journal-title":"N Engl J Med"},{"issue":"8","key":"1073_CR34","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1161\/STROKEAHA.121.038155","volume":"53","author":"Y Peng","year":"2008","unstructured":"Peng Y, Ngo L, Hay K, Alghamry A, Colebourne K, Ranasinghe I. Long-term survival, stroke recurrence, and life expectancy after an acute stroke in Australia and New Zealand from 2008\u20132017: a population-wide cohort study. Stroke. 2008;53(8):2538\u201348.","journal-title":"Stroke"},{"key":"1073_CR35","unstructured":"Rohatgi A. WebPlotDigitizer (Version 4.5). Ankit Rohatgi; 2021."},{"key":"1073_CR36","unstructured":"Australian Bureau of Statistics. Life expectancy 2021\u20132023. In: Statistics ABo, editor. Canberra: Australian Bureau of Statistics; 2021\u20132023."},{"issue":"1","key":"1073_CR37","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s12913-023-09546-w","volume":"23","author":"S Senanayake","year":"2023","unstructured":"Senanayake S, Halahakone U, Abell B, Kularatna S, McCreanor V, McPhail SM, et al. Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis. BMC Health Serv Res. 2023;23(1):512.","journal-title":"BMC Health Serv Res"},{"key":"1073_CR38","volume-title":"A glossary of health economics terms","author":"York Health Economics Consortium","year":"2025","unstructured":"York Health Economics Consortium. A glossary of health economics terms. York: York Health Economics Consortium; 2025."},{"issue":"8","key":"1073_CR39","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s40273-020-00915-5","volume":"38","author":"M Paulden","year":"2020","unstructured":"Paulden M. Why it\u2019s time to abandon the ICER. Pharmacoeconomics. 2020;38(8):781\u20134.","journal-title":"Pharmacoeconomics"},{"key":"1073_CR40","unstructured":"Medicare Benefits Schedule. Medicare Benefits Schedule\u2014Item 707. In: Department of Health DaA, editor. Australian Government; n.d."},{"key":"1073_CR41","unstructured":"Liotta M. Uptake for bowel cancer screening remains low. News GP. 2025."},{"key":"1073_CR42","unstructured":"Health AIo, Welfare. National Cervical Screening Program monitoring report 2024. Canberra: AIHW; 2024."},{"issue":"9921","key":"1073_CR43","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955\u201362.","journal-title":"Lancet"},{"issue":"3","key":"1073_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1474-4422(12)70017-0","volume":"11","author":"H-C Diener","year":"2012","unstructured":"Diener H-C, Eikelboom J, Connolly SJ, Joyner CD, Hart RG, Lip GYH, et al. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurol. 2012;11(3):225\u201331.","journal-title":"Lancet Neurol"},{"issue":"17","key":"1073_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020040","volume":"10","author":"A Gabet","year":"2006","unstructured":"Gabet A, Oli\u00e9 V, B\u00e9jot Y. Atrial fibrillation in spontaneous intracerebral hemorrhage, Dijon stroke registry (2006\u20132017). J Am Heart Assoc. 2006;10(17):e020040.","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"1073_CR46","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1182\/blood-2016-08-731638","volume":"129","author":"RD Lopes","year":"2017","unstructured":"Lopes RD, Guimar\u00e3es PO, Kolls BJ, Wojdyla DM, Bushnell CD, Hanna M, et al. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. Blood. 2017;129(22):2980\u20137.","journal-title":"Blood"},{"key":"1073_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101180","volume":"49","author":"A Wolsink","year":"2025","unstructured":"Wolsink A, Cliteur MP, van Asch CJ, Boogaarts HD, Dammers R, Hannink G, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage, according to age, sex, and country income level: a systematic review and meta-analysis. Lancet Reg Health Eur. 2025;49:101180.","journal-title":"Lancet Reg Health Eur"},{"key":"1073_CR48","unstructured":"Cadilhac DA, Morrison J, Birhanu M, Dalli LL, Paice K, Carter H, et al. The Australian Stroke Clinical Registry Annual Report 2023. Melbourne: The University of Melbourne; 2024. Contract No.: Report No.16."},{"key":"1073_CR49","unstructured":"Australian Government Department of Health Disability and Ageing. Pharmaceutical Benefits Scheme (PBS). 2025. Available from: https:\/\/www.pbs.gov.au\/pbs\/home."},{"issue":"5","key":"1073_CR50","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000538564","volume":"58","author":"TB Abebe","year":"2024","unstructured":"Abebe TB, Ilomaki J, Livori A, Bell JS, Morton JI, Ademi Z. Current and future cost burden of ischemic stroke in Australia: dynamic model. Neuroepidemiology. 2024;58(5):358\u201368.","journal-title":"Neuroepidemiology"},{"key":"1073_CR51","unstructured":"The Campbell and Cochrane Economics Methods Group and the Evidence for Policy and Practice Information and Coordinating Centre. CCEMG-EPPI-Centre Cost Converter. 2022. Available from: https:\/\/eppi.ioe.ac.uk\/costconversion\/."},{"key":"1073_CR52","unstructured":"Kim J, Neville E, Dalli L, Zomer E, Birhanu M, Purvis T, et al. Economic impact of stroke 2024. Melbourne, Australia: Stroke Foundation; 2024."},{"issue":"11","key":"1073_CR53","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1161\/STROKEAHA.114.006200","volume":"45","author":"TD Gloede","year":"2014","unstructured":"Gloede TD, Halbach SM, Thrift AG, Dewey HM, Pfaff H, Cadilhac DA. Long-term costs of stroke using 10-year longitudinal data from the North East Melbourne Stroke Incidence Study. Stroke. 2014;45(11):3389\u201394.","journal-title":"Stroke"},{"issue":"3","key":"1073_CR54","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s11136-023-03558-z","volume":"33","author":"L Redwood","year":"2024","unstructured":"Redwood L, Currow D, Kochovska S, Thomas SJ. Australian population norms for health-related quality of life measured using the EQ-5D-5L, and relationships with sociodemographic characteristics. Qual Life Res. 2024;33(3):721\u201333.","journal-title":"Qual Life Res"},{"key":"1073_CR55","doi-asserted-by":"crossref","unstructured":"Jacobs M, Kaasenbrood F, Postma M, Van Hulst M, Tieleman R. Cost-effectiveness of screening for atrial fibrillation in primary care with a hand-held, single-lead ECG device in the Netherlands. EP Europace. 2016; 20:12-18","DOI":"10.1093\/europace\/euw285"},{"key":"1073_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1219679","volume":"14","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wei Q, Hu H, Liu W, Guan X, Ma A, et al. A systematic review and meta-analysis of health utility values among patients with ischemic stroke. Front Neurol. 2023;14:1219679.","journal-title":"Front Neurol"},{"issue":"1","key":"1073_CR57","first-page":"12","volume":"20","author":"MS Jacobs","year":"2018","unstructured":"Jacobs MS, Kaasenbrood F, Postma MJ, van Hulst M, Tieleman RG. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands. Europace Eur Pacing Arrhythm Card Electrophysiol J Work Groups Cardiac Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2018;20(1):12\u20138.","journal-title":"Europace Eur Pacing Arrhythm Card Electrophysiol J Work Groups Cardiac Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"issue":"4","key":"1073_CR58","doi-asserted-by":"publisher","first-page":"e203767","DOI":"10.1001\/jamanetworkopen.2020.3767","volume":"3","author":"AD Rebchuk","year":"2020","unstructured":"Rebchuk AD, O\u2019Neill ZR, Szefer EK, Hill MD, Field TS. Health utility weighting of the modified Rankin scale: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(4):e203767-e.","journal-title":"JAMA Netw Open"},{"key":"1073_CR59","unstructured":"Australian Institute of Health and Welfare. Profile of Australia's population. AIHW, Australian Government; 2025."},{"issue":"1","key":"1073_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5694\/mja14.00238","volume":"202","author":"J Ball","year":"2015","unstructured":"Ball J, Thompson DR, Ski CF, Carrington MJ, Gerber T, Stewart S. Estimating the current and future prevalence of atrial fibrillation in the Australian adult population. Med J Aust. 2015;202(1):32\u20135.","journal-title":"Med J Aust"},{"issue":"11","key":"1073_CR61","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.hlc.2024.08.008","volume":"33","author":"AD Elliott","year":"2024","unstructured":"Elliott AD, Middeldorp ME, McMullen JR, Fatkin D, Thomas L, Gwynne K, et al. Research priorities for atrial fibrillation in Australia: a statement from the Australian Cardiovascular Alliance Clinical Arrhythmia Theme. Heart Lung Circ. 2024;33(11):1523\u201332.","journal-title":"Heart Lung Circ"},{"issue":"10310","key":"1073_CR62","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","volume":"398","author":"E Svennberg","year":"2021","unstructured":"Svennberg E, Friberg L, Frykman V, Al-Khalili F, Engdahl J, Rosenqvist M. Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet. 2021;398(10310):1498\u2013506.","journal-title":"Lancet"},{"issue":"2","key":"1073_CR63","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1055\/a-1588-8867","volume":"122","author":"W Sun","year":"2022","unstructured":"Sun W, Freedman B, Martinez C, Wallenhorst C, Yan BP. Atrial fibrillation detected by single time-point handheld electrocardiogram screening and the risk of ischemic stroke. Thromb Haemost. 2022;122(2):286\u201394.","journal-title":"Thromb Haemost"},{"key":"1073_CR64","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf139","author":"H Liu","year":"2025","unstructured":"Liu H, Chen Y, Huang B, Lam SHM, Romiti GF, Liu Y, et al. Long-term clinical outcomes of oral anticoagulation in the older patients with atrial fibrillation aged \u226580 years: a report from the GLORIA-AF registry phase III. Age Ageing. 2025. https:\/\/doi.org\/10.1093\/ageing\/afaf139.","journal-title":"Age Ageing"},{"issue":"12","key":"1073_CR65","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/14779072.2023.2276892","volume":"21","author":"LA Verma","year":"2023","unstructured":"Verma LA, Penson PE, Akpan A, Lip GYH, Lane DA. Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches. Expert Rev Cardiovasc Ther. 2023;21(12):963\u201383.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"1073_CR66","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.amjmed.2023.10.027","volume":"137","author":"SZ Goldhaber","year":"2024","unstructured":"Goldhaber SZ, Bassand JP, Camm AJ, Virdone S, Pieper K, Cools F, et al. Clinical outcomes in older patients with atrial fibrillation: insights from the GARFIELD-AF registry. Am J Med. 2024;137(2):128-36.e13.","journal-title":"Am J Med"},{"issue":"1","key":"1073_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41569-022-00803-9","volume":"20","author":"B Freedman","year":"2023","unstructured":"Freedman B, Schnabel RB. Atrial fibrillation screening perspectives after STROKESTOP and LOOP. Nat Rev Cardiol. 2023;20(1):1\u20132.","journal-title":"Nat Rev Cardiol"},{"key":"1073_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd009586.pub3","author":"PS Moran","year":"2016","unstructured":"Moran PS, Teljeur C, Ryan M, Smith SM. Systematic screening for the detection of atrial fibrillation. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.cd009586.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"1073_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcaf099","author":"L Bernfort","year":"2025","unstructured":"Bernfort L, Lyth J, Appelberg K, Boriani G, Buckley CM, Diederichsen SZ, et al. Cost-effectiveness of atrial fibrillation screening programmes across European nations. Eur Heart J Qual Care Clin Outcomes. 2025. https:\/\/doi.org\/10.1093\/ehjqcco\/qcaf099.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"1073_CR70","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010959","volume":"8","author":"J Orchard","year":"2019","unstructured":"Orchard J, Neubeck L, Freedman B, Li J, Webster R, Zwar N, et al. eHealth tools to provide structured assistance for atrial fibrillation screening, management, and guideline-recommended therapy in metropolitan general practice: the AF-SMART study. J Am Heart Assoc. 2019;8(1):e010959.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"1073_CR71","first-page":"14","volume":"21","author":"K Giskes","year":"2020","unstructured":"Giskes K, Hespe C, Freedman B. Screening for atrial fibrillation the essential role of GPs. Med Today (Neutral Bay, NSW). 2020;21(6):14\u201320.","journal-title":"Med Today (Neutral Bay, NSW)."},{"issue":"1","key":"1073_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s44325-024-00014-w","volume":"1","author":"KC Wong","year":"2024","unstructured":"Wong KC, Nguyen TN, Chow CK. Global implementation and evaluation of atrial fibrillation screening in the past two decades\u2014a narrative review. npj Cardiovasc Health. 2024;1(1):17.","journal-title":"npj Cardiovasc Health"},{"issue":"12","key":"1073_CR73","first-page":"1847","volume":"36","author":"JG Andrade","year":"2020","unstructured":"Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC, et al. The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol. 2020;36(12):1847\u2013948.","journal-title":"Can J Cardiol"},{"issue":"1","key":"1073_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","volume":"83","author":"JA Joglar","year":"2023","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol. 2023;83(1):109\u2013279.","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"1073_CR75","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"issue":"7616","key":"1073_CR76","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/bmj.39280.660567.55","volume":"335","author":"DA Fitzmaurice","year":"2007","unstructured":"Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ. 2007;335(7616):383.","journal-title":"BMJ"},{"issue":"1","key":"1073_CR77","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13012-016-0489-0","volume":"11","author":"JS Hocking","year":"2016","unstructured":"Hocking JS, Temple-Smith M, van Driel M, Law M, Guy R, Bulfone L, et al. Can preventive care activities in general practice be sustained when financial incentives and external audit plus feedback are removed? ACCEPt-able: a cluster randomised controlled trial protocol. Implement Sci. 2016;11(1):122.","journal-title":"Implement Sci"},{"key":"1073_CR78","doi-asserted-by":"crossref","unstructured":"Osoro L, Zylla MM, Braunschweig F, Leyva F, Figueras J, P\u00fcrerfellner H, et al. Challenging the status quo: a scoping review of value-based care models in cardiology and electrophysiology. Europace. 2024;26(9).euae210.","DOI":"10.1093\/europace\/euae210"},{"key":"1073_CR79","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jad.2024.01.224","volume":"351","author":"Y Zhai","year":"2024","unstructured":"Zhai Y, Hu F, Yuan L, Ye X, Shi W, Yang R, et al. Atrial fibrillation increases the risk of all-cause dementia, Alzheimer\u2019s disease, and vascular dementia: a cohort study of 373, 415 participants in the UK Biobank. J Affect Disord. 2024;351:323\u201330.","journal-title":"J Affect Disord"},{"issue":"28","key":"1073_CR80","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz386","volume":"40","author":"D Kim","year":"2019","unstructured":"Kim D, Yang P-S, Yu HT, Kim T-H, Jang E, Sung J-H, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. Eur Heart J. 2019;40(28):2313\u201323.","journal-title":"Eur Heart J"},{"issue":"5","key":"1073_CR81","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.121.055018","volume":"145","author":"L Rivard","year":"2022","unstructured":"Rivard L, Friberg L, Conen D, Healey JS, Berge T, Boriani G, et al. Atrial fibrillation and dementia: a report from the AF-SCREEN International Collaboration. Circulation. 2022;145(5):392\u2013409.","journal-title":"Circulation"},{"key":"1073_CR82","volume-title":"Principles and practice of screening for disease","author":"JMG Wilson","year":"1968","unstructured":"Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organisation; 1968."},{"key":"1073_CR83","unstructured":"Australian Government. Population based screening framework. In: Care DoHaA, editor. Canberra Commonwealth of Australia; 2018."},{"issue":"5","key":"1073_CR84","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","volume":"50","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50(5):e1\u201388.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"1073_CR85","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jama.2021.21811","volume":"327","author":"LC Kahwati","year":"2022","unstructured":"Kahwati LC, Asher GN, Kadro ZO, Keen S, Ali R, Coker-Schwimmer E, et al. Screening for atrial fibrillation: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2022;327(4):368\u201383.","journal-title":"JAMA"},{"key":"1073_CR86","unstructured":"United Kingdom National Screening Committee. Adult screening programme atrial fibrillation. 2019. Available from: https:\/\/view-health-screening-recommendations.service.gov.uk\/atrial-fibrillation\/."},{"key":"1073_CR87","volume-title":"Guidelines for preventive activities in general practice","author":"Royal Australian College of General Practitioners","year":"2022","unstructured":"Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 10th ed. Royal Australian College of General Practitioners; 2022.","edition":"10"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-026-01073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-026-01073-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-026-01073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:02:47Z","timestamp":1791554567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-026-01073-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":87,"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1007\/s40258-026-01073-z","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare they have no conflicts of interest relevant to the contents of this article.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication (from Patients\/Participants)","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Upon reasonable request.","order":5,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by UH. Methodological oversight was provided by SS, VM, WP, and DB. The first draft of the manuscript was written by UH, and all authors reviewed and commented on previous versions of the manuscript. SS, VM, WP, and DB supervised the study. All authors read and approved the final manuscript.","order":7,"name":"Ethics","label":"Authors Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}